2012
DOI: 10.1111/j.1529-8027.2012.00412.x
|View full text |Cite
|
Sign up to set email alerts
|

Genetic axonal neuropathies and neuronopathies of pre‐natal and infantile onset

Abstract: The infantile-onset axonal neuropathies and neuronopathies are an uncommon and heterogeneous group of conditions causing weakness, wasting, and developmental delay in early childhood. Many are associated with central nervous system or other systemic manifestations and cause early mortality. We review the axonal Charcot-Marie-Tooth subtypes with onset in infancy, spinal muscular atrophy, and related syndromes of early infancy, giant axonal neuropathy, infantile neuroaxonal dystrophy, hereditary motor and sensor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
2
2
2

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 153 publications
(269 reference statements)
0
17
0
1
Order By: Relevance
“…Neuropathies caused by mutations of the MFN2 gene [8] are classified as CMT2A and account for 3% of infantile neuropathies [9], and 5-30% of CMT2 cases [10]. Thus CMT2A represents the most frequent autosomal dominantly inherited axonal neuropathy.…”
Section: Cmt2a (Mim 609260)mentioning
confidence: 99%
See 3 more Smart Citations
“…Neuropathies caused by mutations of the MFN2 gene [8] are classified as CMT2A and account for 3% of infantile neuropathies [9], and 5-30% of CMT2 cases [10]. Thus CMT2A represents the most frequent autosomal dominantly inherited axonal neuropathy.…”
Section: Cmt2a (Mim 609260)mentioning
confidence: 99%
“…Rapid progression following onset in early childhood and, less commonly, adult onset with slow progression may be seen [10], [15][16][17], occasionally with optic atrophy, pyramidal features, tremor and Parkinsonism [18,19]. The combination of CMT with optic atrophy was previously classified as HMSN VI [10], and that with pyramidal features as HMSN V [20].…”
Section: Clinical Presentationmentioning
confidence: 99%
See 2 more Smart Citations
“…GAN is an “ultra-rare” disease with tens of patients globally (with many likely to be undiagnosed), but neurologists suspect that some CMT Type 2 patients whose causal gene remains unknown may actually have GAN 15 greatly expanding the patient population. GAN generally appears in early childhood and progresses slowly as the neuronal injury becomes more severe.…”
Section: Introductionmentioning
confidence: 99%